Please mark your calendars for this year’s BioInnovate Program Series celebrating life science innovators from Weill Cornell Medicine as well as startup representatives from Cornell University and Cornell Tech.
Join leading investors and industry representatives from organizations including Healthwrx, EpiVax, Fusion Fund, LabyRx, Scion Life Sciences, L.E.K. Consulting, Qiming Venture Partners, and Regeneron for a dynamic series of conversations and events.
This panel of leading life sciences investors and industry representatives will share practical guidance on how academic innovators and spinout teams can strategically engage with potential funders and corporate development partners. The discussion will focus on the intentional steps founders take to secure and maximize high-value interactions with investors and industry, including how to build visibility, credibility, and relationship status.